A retrospective review of non‑intestinal‑type adenocarcinoma of nasal cavity and paranasal sinus

Li,Jinmei; Li,Baofeng; Xu,Jin; Wang,Huimin; Gao,Qingzu; Ye,Feng; Xu,Yuting; Wu,Shuhua; Cheng,Shuqiong; Lu,Yinghao; Guan,Jian; Chen,Bei

doi:10.3892/ol.2023.13718

A retrospective review of non‑intestinal‑type adenocarcinoma of nasal cavity and paranasal sinus

Authors:
- Jinmei Li
- Baofeng Li
- Jin Xu
- Huimin Wang
- Qingzu Gao
- Feng Ye
- Yuting Xu
- Shuhua Wu
- Shuqiong Cheng
- Yinghao Lu
- Jian Guan
- Bei Chen
View Affiliations

Affiliations: Department of Radiation Oncology, Nanfang Hospital, Southern Medical University, Guangzhou, Guangdong 510515, P.R. China, Department of Orthopaedics, General Hospital of Southern Theater Command of PLA, The First School of Clinical Medicine, Southern Medical University, Guangzhou, Guangdong 510010, P.R. China, Department of Pathology, Nanfang Hospital, Southern Medical University, Guangzhou, Guangdong 510515, P.R. China
Published online on: February 14, 2023 https://doi.org/10.3892/ol.2023.13718
Article Number: 132
Copyright: © Li et al. This is an open access article distributed under the terms of Creative Commons Attribution License.

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

Non‑intestinal adenocarcinoma of nasal cavity and paranasal sinuses (n‑ITAC) is a heterogeneous tumor, which has rarely been reported in previous studies. Most high‑grade n‑ITAC has poor prognosis and there is a lack of classic therapeutic strategy. The present study examined using the PACS system of Nanfang Hospital of Southern Medical University between January 2000 and June 2020. It searched the keyword ‘n‑ITAC’ and selected pathology. A total of 15 consecutive patients were searched. Finally, the present study analyzed a total of 12 n‑ITAC patients. The follow‑up time was 47 months on average. For low‑grade (G1) tumors, 1 and 3‑year overall survival (OS) rate were 100 and 85.7% respectively, while for high‑grade (G3) tumors, 1 and 3‑year OS rates were 80.0 and 20.0% respectively. Pathological grade may be an adverse prognostic factor (P=0.077). The OS of the surgery group was significantly superior to that of the non‑surgery group (3‑year OS was 63.6 vs. 0%, P=0.0009). Surgery is an indispensable means of treatment. The OS of patients with positive incisal margin was lower compared with that of patients with negative margin (P=0.186), suggesting that complete resection may be one of the prognostic factors. Patients with high risk factors received radiotherapy. The radiation dose was 66‑70 Gy/33F for patients with positive margin or non‑operation and was 60 Gy/28F for those with negative margin. Most of the patients received prophylactic irradiation of cervical area. Therefore, the prognosis of pathological high‑grade n‑ITAC is poor. Surgery is the most effective and an indispensable treatment for n‑ITAC. For patients with high risk factors, surgery combined with radiotherapy may be a reasonable treatment. With regard to the cover range of radiotherapy, the primary tumor combined with lymph node drainage area is often used in Nanfang Hospital of Southern Medical University and the total dose of radiotherapy can be reduced if the surgical margin is negative.

View Figures

View References

1	Barnes L: Intestinal-type adenocarcinoma of the nasal cavity and paranasal sinuses. Am J Surg Pathol. 10:192–202. 1986. View Article : Google Scholar : PubMed/NCBI
2	Leivo I: Sinonasal adenocarcinoma: Update on classification, immunophenotype and molecular features. Head Neck Pathol. 10:68–74. 2016. View Article : Google Scholar : PubMed/NCBI
3	El-Naggar AK, Chan JKC, Grandis JR, Takata T and Slootweg PJ: WHO classification of head and neck tumours. 4th edition. Lyon; IARC Press: 2017
4	Stelow EB, Jo VY, Mills SE and Carlson DL: A histologic and immunohistochemical study describing the diversity of tumors classified as sinonasal high-grade nonintestinal adenocarcinomas. Am J Surg Pathol. 35:971–980. 2011. View Article : Google Scholar : PubMed/NCBI
5	Heffner DK, Hyams VJ, Hauck KW and Lingeman C: Low-grade adenocarcinoma of the nasal cavity and paranasal sinuses. Cancer. 50:312–322. 1982. View Article : Google Scholar : PubMed/NCBI
6	Knegt PP, Ah-See KW, vd Velden LA and Kerrebijn J: Adenocarcinoma of the ethmoidal sinus complex: Surgical debulking and topical fluorouracil may be the optimal treatment. Arch Otolaryngol Head Neck Surg. 127:141–146. 2001. View Article : Google Scholar : PubMed/NCBI
7	Orvidas LJ, Lewis JE, Weaver AL, Bagniewski SM and Olsen KD: Adenocarcinoma of the nose and paranasal sinuses: A retrospective study of diagnosis, histologic characteristics, and outcomes in 24 patients. Head Neck. 27:370–375. 2005. View Article : Google Scholar : PubMed/NCBI
8	Castelnuovo P, Turri-Zanoni M, Battaglia P, Antognoni P, Bossi P and Locatelli D: Sinonasal malignancies of anterior skull base: Histology-driven treatment strategies. Otolaryngol Clin North Am. 49:183–200. 2016. View Article : Google Scholar : PubMed/NCBI
9	Fiaux-Camous D, Chevret S, Oker N, TurriZanoni M, Lombardi D, Choussy O, Duprez F, Jorissen M, de Gabory L, Malard O, et al: Prognostic value of the seventh AJCC/UICC TNM classification of intestinal-type ethmoid adenocarcinoma: Systematic review and risk prediction model. Head Neck. 39:668–678. 2017. View Article : Google Scholar : PubMed/NCBI
10	Chen MM, Roman SA, Sosa JA and Judson BL: Predictors of survival in sinonasal adenocarcinoma. J Neurol Surg B Skull Base. 76:208–213. 2015. View Article : Google Scholar : PubMed/NCBI
11	Choi HR, Sturgis EM, Rashid A, DeMonte F, Luna MA, Batsakis JG and El-Naggar AK: Sinonasal adenocarcinoma: Evidence for histogenetic divergence of the enteric and nonenteric phenotypes. Hum Pathol. 34:1101–1107. 2003. View Article : Google Scholar : PubMed/NCBI
12	The 8th edition of the American Joint Commission on Cancer (AJCC) TNM staging criteria in 2017. https://dia.dakapath.com/home/tumour/view/id/3640.html
13	Barnes L, Eveson JW, Reichart P and Sidransky D: Pathology and genetics of head and neck tumours. WHO Classification of Tumours. 3rd edition. Vol. 9. Lyon: IARC Press; 2005, https://ovidsp.dc2.ovid.com/ovid–a/ovidweb.cgi?T=JS&PAGE=fulltext&D=ovft&AN=00003524–200685020–00001&NEWS=N&CSC=Y&CHANNEL=PubMed
14	Bignami M, Lepera D, Volpi L, Lambertoni A, Arosio A, Pistochini A, Nicolai P and Castelnuovo P: Sinonasal non-intestinal-type adenocarcinoma: A retrospective review of 22 patients. World Neurosurg. 120:e962–e969. 2018. View Article : Google Scholar : PubMed/NCBI
15	Choussy O, Ferron C, Vedrine PO, Toussaint B, Liétin B, Marandas P, Babin E, De Raucourt D, Reyt E, Cosmidis A, et al: Adenocarcinoma of ethmoid: A GETTEC retrospective multicenter study of 418 cases. Laryngoscope. 118:437–443. 2008. View Article : Google Scholar : PubMed/NCBI
16	Bhayani MK, Yilmaz T, Sweeney A, Calzada G, Roberts DB, Levine NB, DeMonte F, Hanna EY and Kupferman ME: Sinonasal adenocarcinoma: A 16-year experience at a single institution. Head Neck. 36:1490–1496. 2014.PubMed/NCBI
17	Robin TP, Jones BL, Gordon OM, Phan A, Abbott D, McDermott JD, Goddard JA, Raben D, Lanning RM and Karam SD: A comprehensive comparative analysis of treatment modalities for sinonasal malignancies. Cancer. 123:3040–3049. 2017. View Article : Google Scholar : PubMed/NCBI
18	Turner JH and Reh DD: Incidence and survival in patients with sinonasal cancer: A historical analysis of population-based data. Head Neck. 34:877–885. 2012. View Article : Google Scholar : PubMed/NCBI
19	Nicolai P, Schreiber A, Bolzoni Villaret A, Lombardi D, Morassi L, Raffetti E, Donato F, Battaglia P, Turri-Zanoni M, Bignami M and Castelnuovo P: Intestinal type adenocarcinoma of the ethmoid: Outcomes of a treatment regimen based on endoscopic surgery with or without radiotherapy. Head Neck. 38 (Suppl 1):E996–E1003. 2016. View Article : Google Scholar : PubMed/NCBI
20	Nicolai P, Castelnuovo P, Lombardi D, Battaglia P, Bignami M, Pianta L and Tomenzoli D: Role of endoscopic surgery in the management of selected malignant epithelial neoplasms of the naso-ethmoidal complex. Head Neck. 29:1075–1082. 2007. View Article : Google Scholar : PubMed/NCBI
21	Lund VJ, Chisholm EJ, Takes RP, Suárez C, Mendenhall WM, Rinaldo A, Llorente JL, Terhaard CH, Rodrigo JP, Maughan E and Ferlito A: Evidence for treatment strategies in sinonasal adenocarcinoma. Head Neck. 34:1168–1178. 2012. View Article : Google Scholar : PubMed/NCBI
22	Bogaerts S, Vander Poorten V, Nuyts S, Van den Bogaert W and Jorissen M: Results of endoscopic resection followed by radiotherapy for primarily diagnosed adenocarcinomas of the paranasal sinuses. Head Neck. 30:728–736. 2008. View Article : Google Scholar : PubMed/NCBI
23	Jakobsen MH, Larsen SK, Kirkegaard J and Hansen HS: Cancer of the nasal cavity and paranasal sinuses. Prognosis and outcome of treatment. Acta Oncol. 36:27–31. 1997. View Article : Google Scholar : PubMed/NCBI
24	Sakata K, Aoki Y, Karasawa K, Nakagawa K, Hasezawa K, Muta N, Terahara A, Onogi Y, Sasaki Y and Akanuma A: Analysis of the results of combined therapy for maxillary carcinoma. Cancer. 71:2715–2722. 1993. View Article : Google Scholar : PubMed/NCBI
25	Harbo G, Grau C, Bundgaard T, Overgaard M, Elbrønd O, Søgaard H and Overgaard J: Cancer of the nasal cavity and paranasal sinuses. A clinico-pathological study of 277 patients. Acta Oncol. 36:45–50. 1997. View Article : Google Scholar : PubMed/NCBI
26	Parsons JT, Mendenhall WM, Mancuso AA, Cassisi NJ and Million RR: Malignant tumors of the nasal cavity and ethmoid and sphenoid sinuses. Int J Radiat Oncol Biol Phys. 14:11–22. 1988. View Article : Google Scholar : PubMed/NCBI
27	Blanch JL, Ruiz AM, Alos L, Traserra-Coderch J and Bernal-Sprekelsen M: Treatment of 125 sinonasal tumors: Prognostic factors, outcome, and follow-up. Otolaryngol Head Neck Surg. 131:973–976. 2004. View Article : Google Scholar : PubMed/NCBI
28	Choussy O, Ferron C, Védrine PO, Toussaint B, Liétin B, Marandas P, Babin E, De Raucourt D, Reyt E, Cosmidis A, et al: Role of radiotherapy in the treatment of nasoethmoidal adenocarcinoma. Arch Otolaryngol Head Neck Surg. 136:143–146. 2010. View Article : Google Scholar : PubMed/NCBI
29	Van Gerven L, Jorissen M, Nuyts S, Hermans R and Vander Poorten V: Long-term follow-up of 44 patients with adenocarcinoma of the nasal cavity and sinuses primarily treated with endoscopic resection followed by radiotherapy. Head Neck. 33:898–904. 2011. View Article : Google Scholar : PubMed/NCBI
30	Cantù G, Solero CL, Mariani L, Salvatori P, Mattavelli F, Pizzi N and Riggio E: Anterior craniofacial resection for malignant ethmoid tumors-a series of 91 patients. Head Neck. 21:185–191. 1999. View Article : Google Scholar : PubMed/NCBI
31	Dirix P, Vanstraelen B, Jorissen M, Vander Poorten V and Nuyts S: Intensity-modulated radiotherapy for sinonasal cancer: Improved outcome compared to conventional radiotherapy. Int J Radiat Oncol Biol Phys. 78:998–1004. 2010. View Article : Google Scholar : PubMed/NCBI
32	Duprez F, Madani I, Morbée L, Bonte K, Deron P, Domján V, Boterberg T, De Gersem W and De Neve W: IMRT for sinonasal tumors minimizes severe late ocular toxicity and preserves disease control and survival. Int J Radiat Oncol Biol Phys. 83:252–259. 2012. View Article : Google Scholar : PubMed/NCBI
33	Franchi A, Innocenti DR, Palomba A, Miligi L, Paiar F, Franzese C and Santucci M: Low prevalence of K-RAS, EGF-R and BRAF mutations in sinonasal adenocarcinomas. Implications for anti-EGFR treatments. Pathol Oncol Res. 20:571–579. 2014. View Article : Google Scholar : PubMed/NCBI